Report cover image

Hemodialysis Solution

Published Mar 01, 2026
SKU # COG21170465

Description

According to Cognitive Market Research, the global Hemodialysis Solution market size was USD 106251.2 million in 2024. It will expand at a compound annual growth rate (CAGR) of 9.50% from 2024 to 2031.

North America held the major market share for more than 40% of the global revenue with a market size of USD 42500.48 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.7% from 2024 to 2031.

Europe accounted for a market share of over 30% of the global revenue with a market size of USD 31875.36 million.

Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 24437.78 million in 2024 and will grow at a compound annual growth rate (CAGR) of 11.5% from 2024 to 2031.

Latin America had a market share of more than 5% of the global revenue with a market size of USD 5312.56 million in 2024 and will grow at a compound annual growth rate (CAGR) of 8.9% from 2024 to 2031.

Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 2125.02 million in 2024 and will grow at a compound annual growth rate (CAGR) of 9.2% from 2024 to 2031.

The hospitals are the dominant end-user category. This dominance is primarily due to the extensive resources and specialized healthcare professionals available in hospital settings

Table of Contents

Chapter 1 2026 Geopolitical Outlook - Hemodialysis Solution Market Detailed Analysis
Chapter 2 AI's Impact on Market - Detailed Qualitative Analysis
Chapter 3 Global Market Analysis
3.1 Global Hemodialysis Solution Revenue Market Size, Trend Analysis 2022 - 2034
3.2 Global Hemodialysis Solution Market Size By Regions 2022 - 2034
3.2.1 Global Hemodialysis Solution Revenue Market Size By Region
3.3 Global Hemodialysis Solution Market Size By Product 2022 - 2034
3.3.1 Machines Market Size
3.3.2 Dialyzers Market Size
3.3.3 Others Market Size
3.4 Global Hemodialysis Solution Market Size By Service 2022 - 2034
3.4.1 In-center Services Market Size
3.4.2 Home Services Market Size
3.5 Global Hemodialysis Solution Market Size By Modality 2022 - 2034
3.5.1 Conventional Hemodialysis Market Size
3.5.2 Short Daily Hemodialysis Market Size
3.5.3 Nocturnal Hemodialysis Market Size
3.6 Global Hemodialysis Solution Market Size By End-use for 2022 - 2034
3.6.1 Hospitals Market Size
3.6.2 Independent Dialysis Centres Market Size
3.6.3 Others Market Size
3.7 Global Level Competitor Analysis (Subject to Data Availability (Private Players))
3.8 Executive Summary Global Market (2021 vs 2025 vs 2033)
3.8.1 Regional Market Revenue Summary 2021 vs 2025 vs 2033
3.8.2 Global Market Revenue Split By Product
3.8.3 Global Market Revenue Split By Service
3.8.4 Global Market Revenue Split By Modality
3.8.5 Global Market Revenue Split By End-use
3.8.6 Global Market Dynamics, Trends, Drivers, Restraints, Opportunities
Chapter 4 North America Market Analysis
4.1 North America Hemodialysis Solution Market Outlook
4.1.1 North America Hemodialysis Solution Market Size 2022 - 2034
4.1.2 North America Hemodialysis Solution Market Size By Country 2022 - 2034
4.1.3 North America Hemodialysis Solution Market Size by Product 2022 - 2034
4.1.3.1 North America Machines Market Size
4.1.3.2 North America Dialyzers Market Size
4.1.3.3 North America Others Market Size
4.1.4 North America Hemodialysis Solution Market Size by Service 2022 - 2034
4.1.4.1 North America In-center Services Market Size
4.1.4.2 North America Home Services Market Size
4.1.5 North America Hemodialysis Solution Market Size by Modality 2022 - 2034
4.1.5.1 North America Conventional Hemodialysis Market Size
4.1.5.2 North America Short Daily Hemodialysis Market Size
4.1.5.3 North America Nocturnal Hemodialysis Market Size
4.1.6 North America Hemodialysis Solution Market Size by End-use 2022 - 2034
4.1.6.1 North America Hospitals Market Size
4.1.6.2 North America Independent Dialysis Centres Market Size
4.1.6.3 North America Others Market Size
Chapter 5 Europe Market Analysis
5.1 Europe Hemodialysis Solution Market Outlook
5.1.1 Europe Hemodialysis Solution Market Size 2022 - 2034
5.1.2 Europe Hemodialysis Solution Market Size By Country 2022 - 2034
5.1.3 Europe Hemodialysis Solution Market Size by Product 2022 - 2034
5.1.3.1 Europe Machines Market Size
5.1.3.2 Europe Dialyzers Market Size
5.1.3.3 Europe Others Market Size
5.1.4 Europe Hemodialysis Solution Market Size by Service 2022 - 2034
5.1.4.1 Europe In-center Services Market Size
5.1.4.2 Europe Home Services Market Size
5.1.5 Europe Hemodialysis Solution Market Size by Modality 2022 - 2034
5.1.5.1 Europe Conventional Hemodialysis Market Size
5.1.5.2 Europe Short Daily Hemodialysis Market Size
5.1.5.3 Europe Nocturnal Hemodialysis Market Size
5.1.6 Europe Hemodialysis Solution Market Size by End-use 2022 - 2034
5.1.6.1 Europe Hospitals Market Size
5.1.6.2 Europe Independent Dialysis Centres Market Size
5.1.6.3 Europe Others Market Size
Chapter 6 Asia Pacific Market Analysis
6.1 Asia Pacific Hemodialysis Solution Market Outlook
6.1.1 Asia Pacific Hemodialysis Solution Market Size 2022 - 2034
6.1.2 Asia Pacific Hemodialysis Solution Market Size By Country 2022 - 2034
6.1.3 Asia Pacific Hemodialysis Solution Market Size by Product 2022 - 2034
6.1.3.1 Asia Pacific Machines Market Size
6.1.3.2 Asia Pacific Dialyzers Market Size
6.1.3.3 Asia Pacific Others Market Size
6.1.4 Asia Pacific Hemodialysis Solution Market Size by Service 2022 - 2034
6.1.4.1 Asia Pacific In-center Services Market Size
6.1.4.2 Asia Pacific Home Services Market Size
6.1.5 Asia Pacific Hemodialysis Solution Market Size by Modality 2022 - 2034
6.1.5.1 Asia Pacific Conventional Hemodialysis Market Size
6.1.5.2 Asia Pacific Short Daily Hemodialysis Market Size
6.1.5.3 Asia Pacific Nocturnal Hemodialysis Market Size
6.1.6 Asia Pacific Hemodialysis Solution Market Size by End-use 2022 - 2034
6.1.6.1 Asia Pacific Hospitals Market Size
6.1.6.2 Asia Pacific Independent Dialysis Centres Market Size
6.1.6.3 Asia Pacific Others Market Size
Chapter 7 South America Market Analysis
7.1 South America Hemodialysis Solution Market Outlook
7.1.1 South America Hemodialysis Solution Market Size 2022 - 2034
7.1.2 South America Hemodialysis Solution Market Size By Country 2022 - 2034
7.1.3 South America Hemodialysis Solution Market Size by Product 2022 - 2034
7.1.3.1 South America Machines Market Size
7.1.3.2 South America Dialyzers Market Size
7.1.3.3 South America Others Market Size
7.1.4 South America Hemodialysis Solution Market Size by Service 2022 - 2034
7.1.4.1 South America In-center Services Market Size
7.1.4.2 South America Home Services Market Size
7.1.5 South America Hemodialysis Solution Market Size by Modality 2022 - 2034
7.1.5.1 South America Conventional Hemodialysis Market Size
7.1.5.2 South America Short Daily Hemodialysis Market Size
7.1.5.3 South America Nocturnal Hemodialysis Market Size
7.1.6 South America Hemodialysis Solution Market Size by End-use 2022 - 2034
7.1.6.1 South America Hospitals Market Size
7.1.6.2 South America Independent Dialysis Centres Market Size
7.1.6.3 South America Others Market Size
Chapter 8 Middle East Market Analysis
8.1 Middle East Hemodialysis Solution Market Outlook
8.1.1 Middle East Hemodialysis Solution Market Size 2022 - 2034
8.1.2 Middle East Hemodialysis Solution Market Size By Country 2022 - 2034
8.1.3 Middle East Hemodialysis Solution Market Size by Product 2022 - 2034
8.1.3.1 Middle East Machines Market Size
8.1.3.2 Middle East Dialyzers Market Size
8.1.3.3 Middle East Others Market Size
8.1.4 Middle East Hemodialysis Solution Market Size by Service 2022 - 2034
8.1.4.1 Middle East In-center Services Market Size
8.1.4.2 Middle East Home Services Market Size
8.1.5 Middle East Hemodialysis Solution Market Size by Modality 2022 - 2034
8.1.5.1 Middle East Conventional Hemodialysis Market Size
8.1.5.2 Middle East Short Daily Hemodialysis Market Size
8.1.5.3 Middle East Nocturnal Hemodialysis Market Size
8.1.6 Middle East Hemodialysis Solution Market Size by End-use 2022 - 2034
8.1.6.1 Middle East Hospitals Market Size
8.1.6.2 Middle East Independent Dialysis Centres Market Size
8.1.6.3 Middle East Others Market Size
Chapter 9 Africa Market Analysis
9.1 Africa Hemodialysis Solution Market Outlook
9.1.1 Africa Hemodialysis Solution Market Size 2022 - 2034
9.1.2 Africa Hemodialysis Solution Market Size By Country 2022 - 2034
9.1.3 Africa Hemodialysis Solution Market Size by Product 2022 - 2034
9.1.3.1 Africa Machines Market Size
9.1.3.2 Africa Dialyzers Market Size
9.1.3.3 Africa Others Market Size
9.1.4 Africa Hemodialysis Solution Market Size by Service 2022 - 2034
9.1.4.1 Africa In-center Services Market Size
9.1.4.2 Africa Home Services Market Size
9.1.5 Africa Hemodialysis Solution Market Size by Modality 2022 - 2034
9.1.5.1 Africa Conventional Hemodialysis Market Size
9.1.5.2 Africa Short Daily Hemodialysis Market Size
9.1.5.3 Africa Nocturnal Hemodialysis Market Size
9.1.6 Africa Hemodialysis Solution Market Size by End-use 2022 - 2034
9.1.6.1 Africa Hospitals Market Size
9.1.6.2 Africa Independent Dialysis Centres Market Size
9.1.6.3 Africa Others Market Size
Chapter 10 Competitor Analysis (Subject to Data Availability (Private Players))
10.1 Top Competitors Analysis
10.1.1 Global Hemodialysis Solution Market Revenue and Share by Key Players
10.1.2 Top Players Ranking 2024
10.1.3 New Product Launch Analysis
10.1.4 Industry Mergers and Acquisition Analysis
10.2 Company Profile (Data Subject to Availability) Sample Format
10.2.1 Fresenius Medical Care AG & Co. KGaA
10.2.1.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
10.2.1.2 Business Overview
10.2.1.3 Financials (Subject to data availability)
10.2.1.4 R&D Investment (Subject to data availability)
10.2.1.5 Product Types Specification
10.2.1.6 Business Strategy
10.2.1.7 Recent Developments
10.2.1.8 Management Change
10.2.1.9 S.W.O.T Analysis
10.2.2 Baxter International Inc.
10.2.2.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
10.2.2.2 Business Overview
10.2.2.3 Financials (Subject to data availability)
10.2.2.4 R&D Investment (Subject to data availability)
10.2.2.5 Product Types Specification
10.2.2.6 Business Strategy
10.2.2.7 Recent Developments
10.2.2.8 Management Change
10.2.2.9 S.W.O.T Analysis
10.2.3 B. Braun Melsungen AG
10.2.3.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
10.2.3.2 Business Overview
10.2.3.3 Financials (Subject to data availability)
10.2.3.4 R&D Investment (Subject to data availability)
10.2.3.5 Product Types Specification
10.2.3.6 Business Strategy
10.2.3.7 Recent Developments
10.2.3.8 Management Change
10.2.3.9 S.W.O.T Analysis
10.2.4 Nipro Corporation
10.2.4.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
10.2.4.2 Business Overview
10.2.4.3 Financials (Subject to data availability)
10.2.4.4 R&D Investment (Subject to data availability)
10.2.4.5 Product Types Specification
10.2.4.6 Business Strategy
10.2.4.7 Recent Developments
10.2.4.8 Management Change
10.2.4.9 S.W.O.T Analysis
10.2.5 Asahi Kasei Corporation
10.2.5.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
10.2.5.2 Business Overview
10.2.5.3 Financials (Subject to data availability)
10.2.5.4 R&D Investment (Subject to data availability)
10.2.5.5 Product Types Specification
10.2.5.6 Business Strategy
10.2.5.7 Recent Developments
10.2.5.8 Management Change
10.2.5.9 S.W.O.T Analysis
10.2.6 Nikkiso Co.
10.2.6.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
10.2.6.2 Business Overview
10.2.6.3 Financials (Subject to data availability)
10.2.6.4 R&D Investment (Subject to data availability)
10.2.6.5 Product Types Specification
10.2.6.6 Business Strategy
10.2.6.7 Recent Developments
10.2.6.8 Management Change
10.2.6.9 S.W.O.T Analysis
10.2.7 Ltd.
10.2.7.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
10.2.7.2 Business Overview
10.2.7.3 Financials (Subject to data availability)
10.2.7.4 R&D Investment (Subject to data availability)
10.2.7.5 Product Types Specification
10.2.7.6 Business Strategy
10.2.7.7 Recent Developments
10.2.7.8 Management Change
10.2.7.9 S.W.O.T Analysis
10.2.8 Rockwell Medical
10.2.8.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
10.2.8.2 Business Overview
10.2.8.3 Financials (Subject to data availability)
10.2.8.4 R&D Investment (Subject to data availability)
10.2.8.5 Product Types Specification
10.2.8.6 Business Strategy
10.2.8.7 Recent Developments
10.2.8.8 Management Change
10.2.8.9 S.W.O.T Analysis
10.2.9 Inc.
10.2.9.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
10.2.9.2 Business Overview
10.2.9.3 Financials (Subject to data availability)
10.2.9.4 R&D Investment (Subject to data availability)
10.2.9.5 Product Types Specification
10.2.9.6 Business Strategy
10.2.9.7 Recent Developments
10.2.9.8 Management Change
10.2.9.9 S.W.O.T Analysis
10.2.10 Dialife SA
10.2.10.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
10.2.10.2 Business Overview
10.2.10.3 Financials (Subject to data availability)
10.2.10.4 R&D Investment (Subject to data availability)
10.2.10.5 Product Types Specification
10.2.10.6 Business Strategy
10.2.10.7 Recent Developments
10.2.10.8 Management Change
10.2.10.9 S.W.O.T Analysis
10.2.11 NxStage Medical
10.2.11.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
10.2.11.2 Business Overview
10.2.11.3 Financials (Subject to data availability)
10.2.11.4 R&D Investment (Subject to data availability)
10.2.11.5 Product Types Specification
10.2.11.6 Business Strategy
10.2.11.7 Recent Developments
10.2.11.8 Management Change
10.2.11.9 S.W.O.T Analysis
10.2.12 Inc.
10.2.12.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
10.2.12.2 Business Overview
10.2.12.3 Financials (Subject to data availability)
10.2.12.4 R&D Investment (Subject to data availability)
10.2.12.5 Product Types Specification
10.2.12.6 Business Strategy
10.2.12.7 Recent Developments
10.2.12.8 Management Change
10.2.12.9 S.W.O.T Analysis
10.2.13 JMS Co.
10.2.13.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
10.2.13.2 Business Overview
10.2.13.3 Financials (Subject to data availability)
10.2.13.4 R&D Investment (Subject to data availability)
10.2.13.5 Product Types Specification
10.2.13.6 Business Strategy
10.2.13.7 Recent Developments
10.2.13.8 Management Change
10.2.13.9 S.W.O.T Analysis
10.2.14 Ltd.
10.2.14.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
10.2.14.2 Business Overview
10.2.14.3 Financials (Subject to data availability)
10.2.14.4 R&D Investment (Subject to data availability)
10.2.14.5 Product Types Specification
10.2.14.6 Business Strategy
10.2.14.7 Recent Developments
10.2.14.8 Management Change
10.2.14.9 S.W.O.T Analysis
10.2.15 Toray Medical Co.
10.2.15.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
10.2.15.2 Business Overview
10.2.15.3 Financials (Subject to data availability)
10.2.15.4 R&D Investment (Subject to data availability)
10.2.15.5 Product Types Specification
10.2.15.6 Business Strategy
10.2.15.7 Recent Developments
10.2.15.8 Management Change
10.2.15.9 S.W.O.T Analysis
10.2.16 Ltd.
10.2.16.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
10.2.16.2 Business Overview
10.2.16.3 Financials (Subject to data availability)
10.2.16.4 R&D Investment (Subject to data availability)
10.2.16.5 Product Types Specification
10.2.16.6 Business Strategy
10.2.16.7 Recent Developments
10.2.16.8 Management Change
10.2.16.9 S.W.O.T Analysis
10.2.17 Kawasumi Laboratories
10.2.17.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
10.2.17.2 Business Overview
10.2.17.3 Financials (Subject to data availability)
10.2.17.4 R&D Investment (Subject to data availability)
10.2.17.5 Product Types Specification
10.2.17.6 Business Strategy
10.2.17.7 Recent Developments
10.2.17.8 Management Change
10.2.17.9 S.W.O.T Analysis
10.2.18 Inc.
10.2.18.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
10.2.18.2 Business Overview
10.2.18.3 Financials (Subject to data availability)
10.2.18.4 R&D Investment (Subject to data availability)
10.2.18.5 Product Types Specification
10.2.18.6 Business Strategy
10.2.18.7 Recent Developments
10.2.18.8 Management Change
10.2.18.9 S.W.O.T Analysis
10.2.19 Farmasol Ltd.
10.2.19.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
10.2.19.2 Business Overview
10.2.19.3 Financials (Subject to data availability)
10.2.19.4 R&D Investment (Subject to data availability)
10.2.19.5 Product Types Specification
10.2.19.6 Business Strategy
10.2.19.7 Recent Developments
10.2.19.8 Management Change
10.2.19.9 S.W.O.T Analysis
10.2.20 Renacon Pharma Limited
10.2.20.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
10.2.20.2 Business Overview
10.2.20.3 Financials (Subject to data availability)
10.2.20.4 R&D Investment (Subject to data availability)
10.2.20.5 Product Types Specification
10.2.20.6 Business Strategy
10.2.20.7 Recent Developments
10.2.20.8 Management Change
10.2.20.9 S.W.O.T Analysis
10.2.21 Others
10.2.21.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
10.2.21.2 Business Overview
10.2.21.3 Financials (Subject to data availability)
10.2.21.4 R&D Investment (Subject to data availability)
10.2.21.5 Product Types Specification
10.2.21.6 Business Strategy
10.2.21.7 Recent Developments
10.2.21.8 Management Change
10.2.21.9 S.W.O.T Analysis
Chapter 11 Qualitative Analysis (Subject to Data Availability)
11.1 Market Drivers
11.2 Market Restraints
11.3 Market Trends
11.4 Market Opportunity
11.5 Technological Road Map (Subject to Data Availability)
11.6 Product Life Cycle (Subject to Data Availability)
11.7 Consumer Preference Analysis
11.8 Market Attractiveness Analysis
11.9 PESTEL Analysis
11.9.1 Political Factors
11.9.2 Economic Factors
11.9.3 Social Factors
11.9.4 Technological Factors
11.9.5 Legal Factors
11.9.6 Environmental Factors
11.10 Industrial Chain Analysis (Subject to Data Availability)
11.10.1 Industry Chain Analysis
11.10.2 Manufacturing Cost Analysis
11.10.3 Supply Side Analysis
11.10.3.1 Raw Material Analysis
11.10.3.2 Raw Material Procurement Analysis
11.10.3.3 Raw Material Price Trend Analysis
11.11 Porter’s Five Forces Analysis
11.11.1 Bargaining Power of Suppliers
11.11.2 Bargaining Power of Buyers
11.11.3 Threat of New Entrants
11.11.4 Threat of Substitutes
11.11.5 Degree of Competition
11.12 Patent Analysis (Subject to Data Availability)
11.13 ESG Analysis
Chapter 12 Market Split by Product Analysis 2022 - 2034
12.1 Machines
12.1.1 Global Hemodialysis Solution Revenue Market Size and Share by Machines 2022 - 2034
12.2 Dialyzers
12.2.1 Global Hemodialysis Solution Revenue Market Size and Share by Dialyzers 2022 - 2034
12.3 Others
12.3.1 Global Hemodialysis Solution Revenue Market Size and Share by Others 2022 - 2034
Chapter 13 Market Split by Service Analysis 2022 - 2034
13.1 In-center Services
13.1.1 Global Hemodialysis Solution Revenue Market Size and Share by In-center Services 2022 - 2034
13.2 Home Services
13.2.1 Global Hemodialysis Solution Revenue Market Size and Share by Home Services 2022 - 2034
Chapter 14 Market Split by Modality Analysis 2022 - 2034
14.1 Conventional Hemodialysis
14.1.1 Global Hemodialysis Solution Revenue Market Size and Share by Conventional Hemodialysis 2022 - 2034
14.2 Short Daily Hemodialysis
14.2.1 Global Hemodialysis Solution Revenue Market Size and Share by Short Daily Hemodialysis 2022 - 2034
14.3 Nocturnal Hemodialysis
14.3.1 Global Hemodialysis Solution Revenue Market Size and Share by Nocturnal Hemodialysis 2022 - 2034
Chapter 15 Market Split by End-use Analysis 2022 - 2034
15.1 Hospitals
15.1.1 Global Hemodialysis Solution Revenue Market Size and Share by Hospitals 2022 - 2034
15.2 Independent Dialysis Centres
15.2.1 Global Hemodialysis Solution Revenue Market Size and Share by Independent Dialysis Centres 2022 - 2034
15.3 Others
15.3.1 Global Hemodialysis Solution Revenue Market Size and Share by Others 2022 - 2034
Chapter 16 Research Findings
16.1 Key Takeaways
16.2 Analyst Point of View
16.3 Assumptions and Acronyms
Chapter 17 Research Methodology and Sources
17.1 Primary Data Collection
17.1.1 Steps for Primary Data Collection
17.1.1.1 Identification of KOL
17.1.2 Backward Integration
17.1.3 Forward Integration
17.1.4 How Primary Research Help Us
17.1.5 Modes of Primary Research
17.2 Secondary Research
17.2.1 How Secondary Research Help Us
17.2.2 Sources of Secondary Research
17.3 Data Validation
17.3.1 Data Triangulation
17.3.2 Top Down & Bottom Up Approach
17.3.3 Cross check KOL Responses with Secondary Data
17.4 Data Representation
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.